Euroapi SAS
EAPI.PA
| Exchange: | PA |
| Currency | Euro |
| ISIN: | FR0014008VX5 |
| Primary Ticker: | EAPI.PA |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France. |
| Address: | 15 Rue Traversiere, Paris, France, 75012 |
| Website: | https://www.euroapi.com/en |
| Full Time Employees: | 3650 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 392483968 |
| Market Capitalization Mln: | 392.48 |
| EBITDA: | 278400000 |
| Wall Street Target Price: | 3.4 |
| Book Value: | 9.33 |
| Earnings Share: | -3.06 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -0.29 |
| Operating Margin TTM: | 0.03 |
| Return On Equity TTM: | -0.27 |
| Revenue TTM: | 971299968 |
| Revenue Per Share TTM: | 10.28 |
| Quarterly Revenue Growth YOY: | -0.09 |
| Gross Profit TTM: | 176900000 |
| Diluted Eps TTM: | -3.06 |
| Quarterly Earnings Growth YOY: | 2.66 |
Valuation
| Forward PE: | 26.31 |
| Price Sales TTM: | 0.40 |
| Price Book MRQ: | 0.42 |
| Enterprise Value: | 560546974 |
| Enterprise Value Revenue: | 0.57 |
| Enterprise Value Ebitda: | 44.13 |
Shares
| Shares Outstanding: | 95263104 |
| Shares Float: | 50486563 |
| Percent Insiders: | 34.98 |
| Percent Institutions: | 41.49 |
Technicals
| Beta: | 0.56 |
| 52 Week High: | 7.02 |
| 52 Week Low: | 2.26 |
| 50 Day MA: | 3.78 |
| 200 Day MA: | 3.74 |
Earnings
| Report Date: | 2023-04-14 |
| Date: | 2023-03-31 |
| Currency: | EUR |
| Eps Actual: | -0.34 |
| Eps Difference: | -0.34 |
| Report Date: | 2022-09-01 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.01 |
| Eps Difference: | -0.01 |
| Report Date: | 2022-05-03 |
| Date: | 2022-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.16 |
| Eps Difference: | -0.16 |
| Date: | 2023-03-31 |
| Eps Actual: | -0.5 |